We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Nanogen and Fisher Scientific have announced an expansion to their relationship to include a research and development collaboration in molecular diagnostics.
Attempts to cool the brain to reduce injury from stroke and other head trauma may face a significant obstacle: current cooling devices can't penetrate very deeply into the brain.
Collagen Matrix, Inc. announced that it has received FDA's 510(k) clearance of its Collagen Nerve Wrap indicated for the management of peripheral nerve injuries in which there has been no substantial loss of nerve tissue and where gap closure can be achieved by flexion of the extremity.
Medical Solutions, the cancer diagnostics company, announced a major contract with AstraZeneca to provide specialist biomarker assessment services for the development of new cancer drugs.
A jury Aug. 3 issued a split decision in a patent infringement suit brought by Kinetic Concepts (KCI), a manufacturer of wound closure technology and specialty hospital beds, against BlueSky Medical Group and Swiss company Medela AG.
Genetic test makers marketing their products for direct-to-consumer sale can expect to find themselves under a regulatory microscope after a government report found some manufacturers are testing the limits of advertising claims.
Job development officials here are recommending a $500,000 forgivable loan for VisiLED Inc., a medical device manufacturing company seeking to relocate.
Akorn, Inc. announced that it has signed a Definitive Commercial Manufacturing Supply Agreement with Advanced Vision Research Inc. (AVR) for the product, TheraTears(R) lubricant eye drops.